Prostate Cancer - Results from #21120

Escalated-dose versus control-dose conformal radiotherapy for prostate cancer: Long-term results from the MRC RT01 randomised controlled trial - Abstract February 27, 2014

Immunotherapy for prostate cancer: Recent developments and future challenges - Abstract February 26, 2014

Immigration factors and prostate cancer survival among Hispanic men in California: Does neighborhood matter? - Abstract February 26, 2014

Prostate-specific antigen bounce following stereotactic body radiation therapy for prostate cancer - Abstract February 26, 2014

Validation of nomograms predicting lymph node involvement in patients with prostate cancer undergoing extended pelvic lymph node dissection - Abstract February 26, 2014

Nonalcoholic fatty liver disease is a negative risk factor for prostate cancer recurrence - Abstract February 26, 2014

Prognostic value of intraductal carcinoma of the prostate in radical prostatectomy specimens - Abstract February 26, 2014

Low-risk prostate cancer: The accuracy of multiparametric MR imaging for detection - Abstract February 26, 2014

Holmium laser enucleation of the prostate and perioperative diagnosis of prostate cancer: An outcomes analysis - Abstract February 26, 2014

Improved outcomes in elderly patients with metastatic castration-resistant prostate cancer treated with the androgen receptor inhibitor enzalutamide: Results from the phase III AFFIRM trial - Abstract February 26, 2014

Clinical evaluation of abiraterone in the treatment of metastatic prostate cancer - Abstract February 26, 2014

Impact of prednisone on toxicities and survival in metastatic castration-resistant prostate cancer: A systematic review and meta-analysis of randomized clinical trials - Abstract February 26, 2014

Does regular zoledronic acid change the bone turnover of the jaw in men with metastatic prostate cancer: A possible clue to the pathogenesis of bisphosphonate related osteonecrosis of the jaw? - Abstract February 25, 2014

Bone metastases in castration-resistant prostate cancer: Associations between morphologic CT patterns, glycolytic activity, and androgen receptor expression on PET and overall survival - Abstract February 25, 2014

Salvage low-dose-rate brachytherapy for prostate cancer local recurrence after radical prostatectomy: Our first three patients - Abstract February 25, 2014

Prostate cancer boost using high-dose-rate brachytherapy: Early toxicity analysis of 3 different fractionation schemes - Abstract February 25, 2014

Prostate-specific antigen bounce predicts for a favorable prognosis following brachytherapy: A meta-analysis - Abstract February 25, 2014

Time to failure after definitive therapy for prostate cancer: Implications for importance of aggressive local treatment - Abstract February 25, 2014

Localized prostate cancer detection with (18)F FACBC PET/CT: Comparison with MR imaging and histopathologic analysis - Abstract February 25, 2014

Prostate cancer aggressiveness: Assessment with whole-lesion histogram analysis of the apparent diffusion coefficient - Abstract February 25, 2014

Page 1057 of 1435